Friday, February 02, 2007 11:20:49 AM
On January 31, 2007, clickNsettle.com, Inc. (the “Company”) filed a Certificate of Amendment of Certificate of Incorporation with the Secretary of State of the State of Delaware, pursuant to which the Company increased the number of authorized shares of its common stock from 25 million to 300 million. In January 2005, the Company’s shareholders had authorized the Board of Directors, in their sole discretion, to make such an increase. The Board of Directors believed that it was appropriate to do so at this time in order to facilitate a merger transaction or to acquire a different operating business which the Company has been seeking (and which has been disclosed in the Company’s recent Exchange Act periodic filings)
Recent BCDA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 10:14:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2026 12:00:10 PM
- BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency • GlobeNewswire Inc. • 05/21/2026 12:00:00 PM
- BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase • GlobeNewswire Inc. • 05/19/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 12:20:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 09:46:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 12:05:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 12:05:55 PM
- BioCardia Reports First Quarter 2026 Business Highlights and Financial Results • GlobeNewswire Inc. • 05/15/2026 12:00:00 PM
- BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026 • GlobeNewswire Inc. • 05/11/2026 09:10:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 12:00:09 PM
- BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways • GlobeNewswire Inc. • 05/08/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 12:00:08 PM
- BioCardia Announces Allowance of Japanese Patent on Proprietary Heart3D™ Fusion Imaging Software for Procedure Planning and Realtime Navigation During CardiAMP Cell Therapy Procedures • GlobeNewswire Inc. • 04/28/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:04:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 12:00:09 PM
- BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure • GlobeNewswire Inc. • 04/20/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 08:30:15 PM
- BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure • GlobeNewswire Inc. • 04/02/2026 02:11:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 01:00:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 12:05:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:31:26 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/24/2026 08:30:33 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/24/2026 08:05:25 PM
- BioCardia Reports 2025 Business Highlights and Financial Results • GlobeNewswire Inc. • 03/24/2026 08:05:00 PM


